(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are BERGENBIO, EURASIA FONC INV, and FONCIERE EURIS.
Financial Asset | Price | Change | Updated (EST) |
---|---|---|---|
BERGENBIO (BGBIO.OL) | 0.40 | 36.99% | 2023-06-01 11:21:05 |
EURASIA FONC INV (EFI.PA) | 0.36 | 21.48% | 2023-06-01 08:48:21 |
FONCIERE EURIS (EURS.PA) | 1.93 | 19.14% | 2023-06-01 08:49:37 |
NANOBIOTIX (NANO.PA) | 4.91 | 11.21% | 2023-06-01 11:00:45 |
EASE2PAY NV (EAS2P.AS) | 0.99 | 8.79% | 2023-06-01 11:01:52 |
CAMPINE (CAMB.BR) | 61.00 | 7.96% | 2023-06-01 11:06:20 |
INVENTIVA (IVA.PA) | 3.48 | 7.57% | 2023-06-01 11:51:38 |
NHOA (NHOA.PA) | 4.57 | 6.78% | 2023-06-01 11:01:04 |
SCHEERD.V KERCHOVE (SCHD.BR) | 505.00 | 6.54% | 2023-06-01 11:16:36 |
IBA (IBAB.BR) | 15.90 | 6% | 2023-06-01 11:15:14 |
The three biggest losers today are FOUNTAIN, CNOVA, and SAS AB.
Financial Asset | Price | Change | Updated (EST) |
---|---|---|---|
FOUNTAIN (FOU.BR) | 1.00 | -13.48% | 2023-06-01 11:07:14 |
CNOVA (CNV.PA) | 3.30 | -12.47% | 2023-06-01 11:46:26 |
SAS AB (SASNO.OL) | 0.36 | -7.82% | 2023-06-01 08:33:04 |
NAI ORD SHARES (NAI.AS) | 9.25 | -7.5% | 2023-06-01 11:03:22 |
FUT.CLUBE PORTO (FCP.LS) | 1.03 | -6.36% | 2023-06-01 11:18:49 |
MAUNA KEA TECH (MKEA.PA) | 0.64 | -5.47% | 2023-06-01 08:52:26 |
AKVA GROUP (AKVA.OL) | 62.40 | -4.88% | 2023-06-01 11:20:22 |
PIERRE VAC BSA ACT (VACBS.PA) | 0.21 | -4.61% | 2023-06-01 08:01:38 |
EUROPRIS (EPR.OL) | 70.10 | -4.5% | 2023-06-01 11:22:23 |
CASINO GUICHARD (CO.PA) | 5.33 | -4.31% | 2023-06-01 11:45:58 |
Winners today
1. BERGENBIO (BGBIO.OL)
36.99% Price Change
BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of novel medicines to treat immune-evasive, drug resistant, and metastatic cancers; and respiratory diseases. It develops bemcentinib, an oral once-a-day inhibitor of AXL receptor tyrosine kinase, which is in Phase 1b/2a clinical trial to treat non-small cell lung cancer, and Phase 2 clinical trial to treat acute myeloid leukemia and COVID-19. Bemcentinib is also being studied for glioblastoma, 2L lung cancer, melanoma, pancreatic cancer, and mesothelioma. In addition, the company is developing tilvestamab, an anti-AXL function-blocking monoclonal antibody that is in Phase 1b clinical trial for the treatment of ovarian cancer; and mipasetamab uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. It has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.
Oslo Børs Benchmark Index_GI ended the session with BERGENBIO rising 36.99% to €0.40 on Thursday, after three consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.29% to €1,202.00, after five successive sessions in a row of losses, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, BERGENBIO has a trailing twelve months EPS of kr-4.14.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BERGENBIO’s stock is considered to be overbought (>=80).
Volatility
BERGENBIO’s last week, last month’s, and last quarter’s current intraday variation average was a negative 15.96%, a negative 5.64%, and a positive 7.83%.
BERGENBIO’s highest amplitude of average volatility was 15.96% (last week), 18.16% (last month), and 7.83% (last quarter).
Volume
Today’s last reported volume for BERGENBIO is 9268250 which is 561.76% above its average volume of 1400540.
More news about BERGENBIO.
2. EURASIA FONC INV (EFI.PA)
21.48% Price Change
Eurasia Fonciere Investissements Société Anonyme owns, develops, and manages corporate and commercial real estate assets. The company was formerly known as MB Retail Europe and changed its name to Eurasia Fonciere Investissements Société Anonyme in January 2012. The company was founded in 1984 and is headquartered in Paris, France. Eurasia Fonciere Investissements Société Anonyme is a subsidiary of Eurasia Groupe SA.
CAC 40 ended the session with EURASIA FONC INV rising 21.48% to €0.36 on Thursday while CAC 40 jumped 0.55% to €7,137.43.
Earnings Per Share
As for profitability, EURASIA FONC INV has a trailing twelve months EPS of €-0.01.
More news about EURASIA FONC INV.
3. FONCIERE EURIS (EURS.PA)
19.14% Price Change
Foncière Euris SA distributes food and specialized products in France and internationally. The company also owns real estate assets, including shopping centers; and manages commercial real estate properties and private equity portfolio. The company was incorporated in 1970 and is based in Paris, France. Foncière Euris SA operates as a subsidiary of Finatis Société Anonyme.
CAC 40 ended the session with FONCIERE EURIS jumping 19.14% to €1.93 on Thursday, following the last session’s downward trend. CAC 40 rose 0.55% to €7,137.43, after three consecutive sessions in a row of losses, on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, FONCIERE EURIS has a trailing twelve months EPS of €-11.33.
Volume
Today’s last reported volume for FONCIERE EURIS is 5 which is 98.81% below its average volume of 421.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FONCIERE EURIS’s stock is considered to be overbought (>=80).
More news about FONCIERE EURIS.
4. NANOBIOTIX (NANO.PA)
11.21% Price Change
Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.
CAC 40 ended the session with NANOBIOTIX jumping 11.21% to €4.91 on Thursday, after two sequential sessions in a row of losses. CAC 40 jumped 0.55% to €7,137.43, after three sequential sessions in a row of losses, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, NANOBIOTIX has a trailing twelve months EPS of €-1.64.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NANOBIOTIX’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for NANOBIOTIX is 254740 which is 2.64% above its average volume of 248183.
Revenue Growth
Year-on-year quarterly revenue growth grew by 159.6%, now sitting on 4.78M for the twelve trailing months.
More news about NANOBIOTIX.
5. EASE2PAY NV (EAS2P.AS)
8.79% Price Change
Ease2pay N.V. provides online payment services and platform in the Netherlands. It offers payment transaction platform, which offers users services to order and pay in one action and parking solutions. The company was formerly known as DOCDATA N.V. and changed its name to Ease2pay N.V. in February 2018. Ease2pay N.V. is headquartered in Waalwijk, the Netherlands. Ease2pay N.V. is a subsidiary of The Internet of Cars V.O.F.
AEX-Index ended the session with EASE2PAY NV rising 8.79% to €0.99 on Thursday while AEX-Index rose 1% to €756.35.
Earnings Per Share
As for profitability, EASE2PAY NV has a trailing twelve months EPS of €-0.18.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -9.6%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1331%, now sitting on 1.86M for the twelve trailing months.
Volatility
EASE2PAY NV’s last week, last month’s, and last quarter’s current intraday variation average was 14.13%, 1.76%, and 4.59%.
EASE2PAY NV’s highest amplitude of average volatility was 22.43% (last week), 6.70% (last month), and 4.59% (last quarter).
Yearly Top and Bottom Value
EASE2PAY NV’s stock is valued at €0.99 at 22:40 EST, way below its 52-week high of €2.64 and way higher than its 52-week low of €0.57.
Moving Average
EASE2PAY NV’s worth is way higher than its 50-day moving average of €0.88 and way under its 200-day moving average of €1.55.
More news about EASE2PAY NV.
6. CAMPINE (CAMB.BR)
7.96% Price Change
Campine NV engages in the metals recycling and specialty chemicals businesses. It manufactures lead alloys, as well as recovers, treats, and refines lead to produce refined lead ingots. The company also produces antimony trioxide used as flame retardants, polymerization catalysts, and pigment reagents, as well as PET catalysts, and various types of polymer and plastic masterbatches. It operates in Belgium, Germany, Switzerland, Italy, Romania, France, the Netherlands, the United Kingdom, rest of European countries, North America, Asia, and internationally. The company was formerly known as Compagnie Métallurgique de la Campine SA and changed its name to Campine NV in 1992. Campine NV was founded in 1912 and is based in Beerse, Belgium.
BEL 20 ended the session with CAMPINE rising 7.96% to €61.00 on Thursday, after three successive sessions in a row of losses. BEL 20 rose 0.43% to €3,551.92, after three successive sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, CAMPINE has a trailing twelve months EPS of €10.54.
PE Ratio
CAMPINE has a trailing twelve months price to earnings ratio of 5.79. Meaning, the purchaser of the share is investing €5.79 for every euro of annual earnings.
More news about CAMPINE.
7. INVENTIVA (IVA.PA)
7.57% Price Change
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of mucopolysaccharidoses type VI disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.
CAC 40 ended the session with INVENTIVA jumping 7.57% to €3.48 on Thursday while CAC 40 jumped 0.55% to €7,137.43.
Earnings Per Share
As for profitability, INVENTIVA has a trailing twelve months EPS of €-1.47.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, INVENTIVA’s stock is considered to be oversold (<=20).
More news about INVENTIVA.
8. NHOA (NHOA.PA)
6.78% Price Change
NHOA S.A. provides energy storage, E-mobility, and EV fastcharging infrastructure related solutions in France. The company offers solar plus storage, utility-scale storage, and industrial microgrids. It also provides charging services and devices for electric and hybrid vehicles. In addition, the company offers power house, and hybrid house; and HyESS, a technology platform for the transformation of renewables into sustainable grids, as well as Atlante, an eStation that provides fast charging solution. NHOA S.A. is based in Paris, France.
CAC 40 ended the session with NHOA rising 6.78% to €4.57 on Thursday while CAC 40 rose 0.55% to €7,137.43.
Earnings Per Share
As for profitability, NHOA has a trailing twelve months EPS of €-1.51.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -58.43%.
Yearly Top and Bottom Value
NHOA’s stock is valued at €4.57 at 22:40 EST, way under its 52-week high of €14.06 and way higher than its 52-week low of €3.15.
Revenue Growth
Year-on-year quarterly revenue growth grew by 262.7%, now sitting on 165.69M for the twelve trailing months.
Moving Average
NHOA’s value is way under its 50-day moving average of €5.10 and way under its 200-day moving average of €8.62.
More news about NHOA.
9. SCHEERD.V KERCHOVE (SCHD.BR)
6.54% Price Change
Scheerders van Kerchove's Verenigde fabrieken nv manufactures and distributes building materials. It offers façade panels, slates, facing bricks, and corrugated sheets. The company was founded in 1905 and is based in Sint-Niklaas, Belgium.
BEL 20 ended the session with SCHEERD.V KERCHOVE rising 6.54% to €505.00 on Thursday while BEL 20 jumped 0.43% to €3,551.92.
Earnings Per Share
As for profitability, SCHEERD.V KERCHOVE has a trailing twelve months EPS of €-2.83.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.06%.
Moving Average
SCHEERD.V KERCHOVE’s worth is higher than its 50-day moving average of €502.04 and below its 200-day moving average of €528.03.
Volume
Today’s last reported volume for SCHEERD.V KERCHOVE is 1 which is 88.88% below its average volume of 9.
More news about SCHEERD.V KERCHOVE.
10. IBA (IBAB.BR)
6% Price Change
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.
BEL 20 ended the session with IBA jumping 6% to €15.90 on Thursday while BEL 20 jumped 0.43% to €3,551.92.
Earnings Per Share
As for profitability, IBA has a trailing twelve months EPS of €0.2.
PE Ratio
IBA has a trailing twelve months price to earnings ratio of 79.5. Meaning, the purchaser of the share is investing €79.5 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.01%.
Volume
Today’s last reported volume for IBA is 52783 which is 297.4% above its average volume of 13282.
More news about IBA.
Losers Today
1. FOUNTAIN (FOU.BR)
-13.48% Price Change
Fountain S.A. engages in the sale, rental, and provision of machines for cold and hot drinks made from freeze-dried or grain products in Europe. It provides coffee and cartridge machines, and other beverages machines. The company offers its products through independent distributors. Fountain S.A. was founded in 1972 and is based in Braine-l'Alleud, Belgium.
BEL 20 ended the session with FOUNTAIN dropping 13.48% to €1.00 on Thursday while BEL 20 rose 0.43% to €3,551.92.
Earnings Per Share
As for profitability, FOUNTAIN has a trailing twelve months EPS of €-0.14.
Volume
Today’s last reported volume for FOUNTAIN is 400 which is 136.68% above its average volume of 169.
More news about FOUNTAIN.
2. CNOVA (CNV.PA)
-12.47% Price Change
Cnova N.V. operates as an e-commerce company in France and Western Europe. The company offers home appliances, consumer electronics, computers, home furnishings, and leisure and personal goods through its cdiscount.com website. It also operates Cdiscount Voyages, a travel platform; Cdiscount Mobile for cell phone plans; Cdiscount Advertising, a digital marketing solution; Octopia for turnkey marketplace solutions to retailers and e-merchants; and C-Logistics for transportation and logistics services. The company was founded in 1998 and is headquartered in Amsterdam, the Netherlands. Cnova N.V. is a subsidiary of Casino, Guichard-Perrachon S.A.
CAC 40 ended the session with CNOVA falling 12.47% to €3.30 on Thursday, after three consecutive sessions in a row of losses. CAC 40 rose 0.55% to €7,137.43, after three sequential sessions in a row of losses, on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, CNOVA has a trailing twelve months EPS of €-0.38.
Volatility
CNOVA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.91%, a negative 0.78%, and a positive 5.58%.
CNOVA’s highest amplitude of average volatility was 4.17% (last week), 4.45% (last month), and 5.58% (last quarter).
More news about CNOVA.
3. SAS AB (SASNO.OL)
-7.82% Price Change
SAS AB (publ), together with its subsidiaries, provides passenger flight transportation services in the Nordic and international route network. The company also offers air cargo services, in-flight sales, ground handling, and technical maintenance services, as well as travel-related loyalty programs. It operates a fleet of 135 aircraft, including 12 long-haul aircraft, 95 short-haul aircraft, and 28 aircraft flown by regional production partners. The company was founded in 1946 and is headquartered in Stockholm, Sweden. On July 5, 2022, SAS AB (publ), along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.
Oslo Børs Benchmark Index_GI ended the session with SAS AB falling 7.82% to €0.36 on Thursday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.29% to €1,202.00, after five consecutive sessions in a row of losses, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, SAS AB has a trailing twelve months EPS of kr-1.32.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1151.97%.
More news about SAS AB.
4. NAI ORD SHARES (NAI.AS)
-7.5% Price Change
New Amsterdam Invest N.V. focuses on acquiring a stake in company active as an operating company in the real estate sector primarily in Europe and the United States. The company was incorporated in 2021 and is based in Amsterdam, the Netherlands.
AEX-Index ended the session with NAI ORD SHARES falling 7.5% to €9.25 on Thursday, after two sequential sessions in a row of gains. AEX-Index rose 1% to €756.35, after three consecutive sessions in a row of losses, on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, NAI ORD SHARES has a trailing twelve months EPS of €-0.42.
Volatility
NAI ORD SHARES’s last week, last month’s, and last quarter’s current intraday variation average was 2.60%, 0.20%, and 3.15%.
NAI ORD SHARES’s highest amplitude of average volatility was 2.60% (last week), 4.30% (last month), and 3.15% (last quarter).
More news about NAI ORD SHARES.
5. FUT.CLUBE PORTO (FCP.LS)
-6.36% Price Change
Futebol Clube do Porto – Futebol, S.A.D., together with its subsidiaries, participates in professional football competitions, and the sporting events promotion and organization in Portugal. It also engages in the image rights commercialization, sponsoring, merchandising, and products licensing activities; production, editing, and commercialization of multimedia material, as well as Internet, periodical, and non-periodical publications; and sport equipment management and exploration business, as well as insurance broking activities. In addition, the company organizes and sells travel and tour packages; and tickets and seat reservations, as well as represents travel agencies and tourism. Further, it is involved in the concept, design, development, production, direction, promotion, marketing, acquisition, exploration rights, recording, distribution, and dissemination of works and audiovisual programs, multimedia, television, video, cinema, theme, Internet, channels, tourist events, and cultural and sporting in any formats and systems. Additionally, the company manages, operates, and provides services in the areas of recording, production, and communication of audiovisual works, television shows, sounds, images, and other audiovisuals; and edits periodic publicities, books, and multimedia. It also explores for the Porto Canal cable television channel; and produces and executes advertisings, news reports, documentaries, and TV programs in video support. The company was founded in 1893 and is headquartered in Porto, Portugal.
PSI ended the session with FUT.CLUBE PORTO dropping 6.36% to €1.03 on Thursday, following the last session’s upward trend. PSI rose 1.27% to €5,802.17, after two sequential sessions in a row of losses, on what was an all-around bullish trend trading session today.
Earnings Per Share
As for profitability, FUT.CLUBE PORTO has a trailing twelve months EPS of €0.98.
PE Ratio
FUT.CLUBE PORTO has a trailing twelve months price to earnings ratio of 1.05. Meaning, the purchaser of the share is investing €1.05 for every euro of annual earnings.
Moving Average
FUT.CLUBE PORTO’s worth is higher than its 50-day moving average of €1.00 and way above its 200-day moving average of €0.90.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FUT.CLUBE PORTO’s stock is considered to be oversold (<=20).
More news about FUT.CLUBE PORTO.
6. MAUNA KEA TECH (MKEA.PA)
-5.47% Price Change
Mauna Kea Technologies SA develops and markets medical devices in Europe and internationally. The company offers range of medical devices, which includes gastroenterology, pulmonology, urology, and drug development. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions. The company was incorporated in 2000 and is headquartered in Paris, France.
CAC 40 ended the session with MAUNA KEA TECH sliding 5.47% to €0.64 on Thursday while CAC 40 rose 0.55% to €7,137.43.
Earnings Per Share
As for profitability, MAUNA KEA TECH has a trailing twelve months EPS of €-0.25.
More news about MAUNA KEA TECH.
7. AKVA GROUP (AKVA.OL)
-4.88% Price Change
AKVA group ASA designs, purchases, manufactures, assembles, sells, and installs technology products; and provides rental and consulting services for the aquaculture industry. The company operates through three segments: Sea Based Technology (SBT), Digital, and Land Based Technology. The SBT segment offers plastic cages, steel cages, fish farming cages, feed barges, feed systems, sensor and camera systems, light systems, net cleaning systems, remotely operating vehicles, and nets and mooring systems under the Polarcirkel, Wavemaster, and Akvasmart hardware brands. This segment also supplies polyethylene boats and pipes to aquaculture and other industries, as well as plastic pen. The Digital segment provides production control, planning, traceability, and ERP software for the aquaculture and fishing industries under the Fishtalk, AKVAconnect, and AKVA Observe. The Land Based Technology segment designs and delivers recirculation systems for land-based fish farming, as well as provides water quality conditions for fresh and seawater operations. AKVA group ASA operates in Norway, Chile, the United Kingdom, Denmark, Canada, and internationally. The company was incorporated in 1982 and is based in Klepp Stasjon, Norway. AKVA group ASA is a subsidiary of Egersund Group AS.
Oslo Børs Benchmark Index_GI ended the session with AKVA GROUP falling 4.88% to €62.40 on Thursday while Oslo Børs Benchmark Index_GI jumped 0.29% to €1,202.00.
Earnings Per Share
As for profitability, AKVA GROUP has a trailing twelve months EPS of kr-4.43.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.65%.
Volume
Today’s last reported volume for AKVA GROUP is 1553 which is 66.15% below its average volume of 4588.
More news about AKVA GROUP.
8. PIERRE VAC BSA ACT (VACBS.PA)
-4.61% Price Change
CAC 40 ended the session with PIERRE VAC BSA ACT sliding 4.61% to €0.21 on Thursday while CAC 40 rose 0.55% to €7,137.43.
More news about PIERRE VAC BSA ACT.
9. EUROPRIS (EPR.OL)
-4.5% Price Change
Europris ASA operates as a discount variety retailer in Norway. It sells own brand and branded merchandise, including groceries, animal, leisure time, home and interior, house and garden, kitchen, clothes, storage, and personal care products. The company also offers its products through online shopping. Europris ASA was incorporated in 2011 and is headquartered in Rolvsøy, Norway.
Oslo Børs Benchmark Index_GI ended the session with EUROPRIS dropping 4.5% to €70.10 on Thursday, after four consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.29% to €1,202.00, after five successive sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, EUROPRIS has a trailing twelve months EPS of kr6.23.
PE Ratio
EUROPRIS has a trailing twelve months price to earnings ratio of 11.25. Meaning, the purchaser of the share is investing kr11.25 for every norwegian krone of annual earnings.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUROPRIS’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for EUROPRIS is 3277110 which is 892.04% above its average volume of 330339.
Volatility
EUROPRIS’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.09%, a negative 0.22%, and a positive 1.24%.
EUROPRIS’s highest amplitude of average volatility was 1.09% (last week), 1.17% (last month), and 1.24% (last quarter).
More news about EUROPRIS.
10. CASINO GUICHARD (CO.PA)
-4.31% Price Change
Casino, Guichard-Perrachon S.A. operates as a food retailer in France, Latin America, and internationally. The company operates hypermarkets, supermarkets, shopping malls, and e-commerce sites, as well as convenience, discount, and cash and carry stores. It also involved in banking, digital marketing, service station, franchise, real estate asset management, property development and trading, rental, banking, and energy-related activities. It operates through stores. The company was founded in 1898 and is based in Saint-Étienne, France.
CAC 40 ended the session with CASINO GUICHARD falling 4.31% to €5.33 on Thursday, after five sequential sessions in a row of losses. CAC 40 jumped 0.55% to €7,137.43, after three successive sessions in a row of losses, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, CASINO GUICHARD has a trailing twelve months EPS of €-3.02.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.53%.
Moving Average
CASINO GUICHARD’s value is way below its 50-day moving average of €6.85 and way under its 200-day moving average of €9.72.
More news about CASINO GUICHARD.
Stay up to date with our winners and losers daily report